Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008530
Filing Date
2017-11-08
Accepted
2017-11-08 16:03:26
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20170930x10q.htm 10-Q 1426055
2 EX-31.1 coll-20170930ex3116f6827.htm EX-31.1 15946
3 EX-31.2 coll-20170930ex312a7f9f3.htm EX-31.2 16092
4 EX-32.1 coll-20170930ex321e9e52a.htm EX-32.1 8485
5 EX-32.2 coll-20170930ex322b0cf6d.htm EX-32.2 8513
  Complete submission text file 0001558370-17-008530.txt   4835427

Data Files

Seq Description Document Type Size
6 EX-101.INS coll-20170930.xml EX-101.INS 976043
7 EX-101.SCH coll-20170930.xsd EX-101.SCH 29980
8 EX-101.CAL coll-20170930_cal.xml EX-101.CAL 34732
9 EX-101.DEF coll-20170930_def.xml EX-101.DEF 81766
10 EX-101.LAB coll-20170930_lab.xml EX-101.LAB 320143
11 EX-101.PRE coll-20170930_pre.xml EX-101.PRE 228938
Mailing Address 780 DEDHAM STREET, SUITE 800 CANTON MA 02021
Business Address 780 DEDHAM STREET, SUITE 800 CANTON MA 02021 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 171186545
SIC: 2834 Pharmaceutical Preparations